incretin mimetics glp 1 agonists Schematic Mechanism of in lowering the blood glucose Structures of formulations of GLP-1

Lessons From Bariatric Surgery: Can Increased GLP-1 Enhance Vascular Repair During Cardiometabolic-Based Chronic Disease

MicroRNA-145 negatively regulates cell proliferation through targeting IRS1 in isolated ovarian granulosa cells from patients with polycystic ovary syndrome

The prescribing information also includes a boxed warning for thyroid C-cell tumors and several other important precautions

GLP-1 works beautifullystimulating insulin, suppressing glucagon, and slowing gastric emptyingbut it has a fatal flaw: It is destroyed by the enzyme DPP-4 within minutes of entering the bloodstream

Clinical evidence Evidence among individuals with diabetes Major cardiovascular outcome trials of GLP-1 RAs in individuals with T2DM have consistently demonstrated modest reductions in SBP (Table 1)

doi:10.1101/2023.11.19.23298750 117